Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-19-021141

Options or other derivatives

  • Chief Financial Officer acquired 62,715 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Saik Andrew · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-06 Grant or award : show line 1 in the form Stock Option (Right To Purchase) +62,715 62,715 D
Loading xslF345X03/form4.xml…